Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NicOx and Merck & Co. expand license agreement for new NO donors

Sep. 16, 2010

Bachem and Atheris collaborate on Melusine peptide toxin libraries

Sep. 15, 2010

Ensemble Therapeutics describes Ensemblins

Sep. 15, 2010

Anchor Therapeutics and Ortho-McNeil-Janssen to codevelop GPCR-targeted drugs

Sep. 13, 2010

Results reported from study of Cerus' INTERCEPT Blood System

Sep. 3, 2010

Cerus regains commercial rights to Intercept blood system from BioOne

Aug. 25, 2010

Vyteris to license Georgia Tech's transdermal drug delivery technologies

Aug. 25, 2010

Anchor Therapeutics secures funds to advance pepducin drug candidates

Aug. 23, 2010

In vitro repopulation of lung matrix yields bioartificial lungs suitable for in vivo implantation

Aug. 18, 2010

Allozyne partners with Sigma-Aldrich for cycloaddition chemistry

Aug. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...